Article
Publicly Available
Education and Training in Laboratory Medicine
Published/Copyright:
October 21, 2021
Published Online: 2021-10-21
Published in Print: 2021-11-25
© 2021 Walter de Gruyter GmbH, Berlin/Boston
Articles in the same Issue
- Frontmatter
- Committees
- Contents
- Speakers Abstracts
- Educational Workshop Abstracts
- Advanced technologies, including new biomarker discovery
- Analytical technologies and applications
- Artificial intelligence - Informatics
- Atherosclerosis, including lipids and other risk markers
- Audit
- Autoimmune diseases , including allergy
- Bioinformatics, including data management
- Biomarkers in cancer
- Bone metabolism
- Cardiovascular diseases, including cardiac markers
- Case report
- Clinical Studies - Outcomes
- Diabetes, obesity, metabolic syndrome
- Education and Training in Laboratory Medicine
- Endocrinology, not including diabetes
- Evidence based medicine, including Guidelines
- Gastrointestinal diseases, including hepatic and pancreatic diseases
- Genetic diseases
- Haematology, including haemostasis
- Inflammation, vascular biology, endothelium, and oxidative stress
- Inherited disorders, metabolic disorders and rare diseases
- Kidney diseases
- Laboratory and Sports medicine
- Laboratory Management, Accreditation, Quality Assurance, performance specification
- Microbiology - Infectious diseases including COVID 19
- Molecular diagnostics, including epigenetics
- Neonatal and paediatric laboratory medicine, including prenatal testing
- Neurological diseases
- Nutrition, including vitamins and trace elements
- Other
- Personalised Medicine, including pharmacogenetics
- Point of Care testing, critical care, emergency medicine.
- Reference intervals and decision limits
- Total Testing Process, including standardisation, preanalytical process
- Toxicology, including therapeutic drug monitoring
- Urinalysis
Articles in the same Issue
- Frontmatter
- Committees
- Contents
- Speakers Abstracts
- Educational Workshop Abstracts
- Advanced technologies, including new biomarker discovery
- Analytical technologies and applications
- Artificial intelligence - Informatics
- Atherosclerosis, including lipids and other risk markers
- Audit
- Autoimmune diseases , including allergy
- Bioinformatics, including data management
- Biomarkers in cancer
- Bone metabolism
- Cardiovascular diseases, including cardiac markers
- Case report
- Clinical Studies - Outcomes
- Diabetes, obesity, metabolic syndrome
- Education and Training in Laboratory Medicine
- Endocrinology, not including diabetes
- Evidence based medicine, including Guidelines
- Gastrointestinal diseases, including hepatic and pancreatic diseases
- Genetic diseases
- Haematology, including haemostasis
- Inflammation, vascular biology, endothelium, and oxidative stress
- Inherited disorders, metabolic disorders and rare diseases
- Kidney diseases
- Laboratory and Sports medicine
- Laboratory Management, Accreditation, Quality Assurance, performance specification
- Microbiology - Infectious diseases including COVID 19
- Molecular diagnostics, including epigenetics
- Neonatal and paediatric laboratory medicine, including prenatal testing
- Neurological diseases
- Nutrition, including vitamins and trace elements
- Other
- Personalised Medicine, including pharmacogenetics
- Point of Care testing, critical care, emergency medicine.
- Reference intervals and decision limits
- Total Testing Process, including standardisation, preanalytical process
- Toxicology, including therapeutic drug monitoring
- Urinalysis